Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Standardized Whole-Blood Immunometabolism Assay
2026-09-08
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with pharmacological modulation of cellular metabolism. The workflow preserves the complexity of human blood while enabling quantitative cytokine analysis, providing a practical framework for studying how glycolysis and other metabolic pathways shape immune responses.
-
Cyclo (-RGDfC) for Reliable Integrin Assays
2026-09-08
This scenario-driven guide explains how Cyclo (-RGDfC), SKU A8790, can strengthen αvβ3 integrin experiments involving cell adhesion, migration, viability, and cytotoxicity readouts. It connects formulation, assay controls, protocol design, and supplier-selection decisions to practical laboratory reproducibility.
-
Chicken ANP32A and Avian Influenza Polymerase
2026-09-07
This preprint identifies three cooperating determinants in chicken ANP32A—a SUMO-interacting motif, SUMOylation at K68/K153, and a segment of the avian-specific insertion—that enable efficient support of avian influenza virus polymerase. Its gain-and-loss-of-function framework explains why mammalian ANP32A/B, which lack two of these features, provide weaker support and offers a mechanistic view of host restriction.
-
JC-1 Mitochondrial Membrane Potential Assay Kit Guide
2026-09-07
Use ratiometric JC-1 fluorescence to connect mitochondrial depolarization with apoptosis, drug response, and mitochondrial function analysis. This practical guide covers controls, workflow design, assay optimization, and how to interpret ΔΨm changes alongside the immunomodulatory findings reported for glabridin-gold(I) complex 6d.
-
Cyclo (-RGDfC) for High-Throughput Integrin Assays
2026-09-05
Cyclo (-RGDfC) combines cyclic RGD recognition with a practical DMSO-based workflow for αvβ3 integrin studies. Paired with 96-well hydrogel printing and localized light activation, c(RGDfC) can support spatially resolved adhesion, migration, angiogenesis, and tumor-targeting experiments.
-
HOBt in Peptide Coupling and Indazole SAR
2026-09-04
HOBt (1-Hydroxybenzotriazole) is more than a conventional peptide coupling additive: its activated-ester chemistry can shape stereochemical quality and downstream medicinal chemistry decisions. This article connects HOBt-enabled amide bond formation with the modular synthesis and assay interpretation of indazole glucagon receptor antagonists.
-
BOP Reagent for Prodrug Synthesis Workflows
2026-09-04
BOP reagent provides a practical route to carboxyl group activation, phenyl ester preparation, and controlled amide bond formation in research-scale synthesis. This workflow guide connects peptide-coupling discipline with carrier-free triterpene prodrug research while clearly separating established study findings from proposed chemical adaptations.
-
Clozapine N-oxide for DREADDs Workflows
2026-09-03
Clozapine N-oxide (CNO) enables reversible, cell-selective control of neuronal circuits through engineered muscarinic receptors. This workflow-oriented guide shows how to apply it to aversion studies, GPCR signaling research, assay validation, and troubleshooting without overinterpreting behavioral outcomes.
-
Octyl-α-ketoglutarate: A Causal HIF-1α Assay Tool
2026-09-03
Octyl-α-ketoglutarate is a cell-permeable prolyl hydroxylase substrate for testing how α-ketoglutarate availability shapes HIF-1α regulation. This guide presents a causal assay framework that separates substrate rescue from broader metabolic and hypoxia effects.
-
CP-673451 Workflow for PDGFRα/β Research
2026-09-02
CP-673451 is a selective PDGFRα/β inhibitor for linking receptor phosphorylation, PDGF-BB-driven angiogenesis, and glioma cell phenotypes in one experimental strategy. This practical guide covers dose design, ATRX-stratified assays, xenograft interpretation, formulation, and troubleshooting.
-
Tomivosertib: Translating MNK–eIF4E Biology
2026-09-02
Tomivosertib is more than a potent MNK1 inhibitor: it is a translational probe for testing how MNK1/2-dependent eIF4E phosphorylation shapes leukemic fitness, treatment response, neuronal excitability, angiogenesis, and metabolic adaptation. This article outlines the mechanistic rationale, evidence hierarchy, assay strategy, and decision points needed to move MNK-eIF4E research toward clinically relevant hypotheses.
-
Ertugliflozin (PF-04971729) Research Workflows
2026-09-01
Build cleaner renal glucose transport assays with the highly selective SGLT2 inhibitor Ertugliflozin (PF-04971729). This workflow-focused guide connects glucose reabsorption inhibition with body-weight, renal, cardiovascular, and fracture-safety readouts while emphasizing practical controls and troubleshooting.
-
Ibuprofen Workflows for Cell and Cancer Research
2026-09-01
Build more reproducible Ibuprofen experiments by connecting solvent handling, dose design, apoptosis induction in colon carcinoma cells, and cell-cycle profiling. This guide also adapts a protein–ligand workflow from a molecular pharmacology study without treating findings from mubritinib as direct evidence for Ibuprofen.
-
Fingolimod (FTY720) for Immune-Cell Assays
2026-08-31
Fingolimod (FTY720) gives researchers a controllable way to interrogate S1P-dependent lymphocyte trafficking, ERK signaling, and BDNF-associated neurobiology. Used as a mechanistic perturbation rather than an unproven CAR-T component, it can sharpen magnetic T-cell engineering assays and reveal how cell distribution affects efficacy.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-08-31
Grafton et al. developed a scalable phenotypic screening strategy that combines induced pluripotent stem cell-derived cardiomyocytes, high-content imaging, and deep learning to detect cardiotoxic patterns. Screening 1,280 bioactive compounds showed that a single deep-learning score could prioritize chemically and mechanistically diverse liabilities, while also revealing the need for orthogonal validation before biological or regulatory decisions.